Edition:
India

NuVasive Inc (NUVA.OQ)

NUVA.OQ on NASDAQ Stock Exchange Global Select Market

52.22USD
24 Apr 2018
Change (% chg)

$-0.80 (-1.51%)
Prev Close
$53.02
Open
$53.18
Day's High
$53.30
Day's Low
$51.56
Volume
137,199
Avg. Vol
285,815
52-wk High
$81.48
52-wk Low
$44.62

Chart for

About

Nuvasive, Inc. is a medical device company. The Company focuses on developing minimally-disruptive surgical products and procedurally-integrated solutions for the spine surgery. Its product portfolio focuses on applications for spine fusion surgery, including biologics used to aid in the spinal fusion process. Its principal... (more)

Overall

Beta: 0.79
Market Cap(Mil.): $2,893.28
Shares Outstanding(Mil.): 50.80
Dividend: --
Yield (%): --

Financials

BRIEF-Nuvasive Posts Q4 Adj. Earnings Per Share $0.56

* NUVASIVE REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

27 Feb 2018

BRIEF-John DeFord To Join NuVasive Board Of Directors

* NUVASIVE INC - AS A RESULT OF DEFORD'S APPOINTMENT, NUVASIVE BOARD OF DIRECTORS CONSISTS OF 10 DIRECTORS Source text for Eikon: Further company coverage:

09 Feb 2018

BRIEF-NuVasive Comments On Expected Impact Of U.S. Tax Reform

* NUVASIVE INC - ‍SAVINGS FROM TAX REFORM EXPECTED TO BOOST FORWARD-LOOKING FREE CASH FLOW, NON-GAAP EPS IN EXCESS OF 10 % PER YEAR BEGINNING IN 2018​

21 Dec 2017

BRIEF-Nuvasive To Acquire Safepassage

* NUVASIVE INC - NUVASIVE EXPECTS TRANSACTION TO BE ACCRETIVE TO COMPANY'S NON-GAAP EARNINGS PER SHARE (EPS) IN 2018 AND BEYOND

13 Dec 2017

Earnings vs. Estimates